Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Insurance
    • Rs 1 crore health...

    Rs 1 crore health insurance policy soon, courtesy New India Assurance

    Written by supriya kashyap kashyap Published On 2016-12-01T13:17:57+05:30  |  Updated On 1 Dec 2016 1:17 PM IST
    Rs 1 crore health insurance policy soon, courtesy New India Assurance

    Coimbatore : Public sector New India Assurance Company Ltd said it has formulated a health insurance scheme for high net-worth individuals with a sum insured of up to Rs 1 crore and was awaiting the approval of the Insurance Regulatory and Development Authority of India (IRDAI) for the launch.


    The new product would have advance features and the sum insured could go up as high as Rs 1 crore and the approval of IRDAI was expected in one month, New India Assurance Chairman-cum-Managing Director G Srinivasan told reporters here.


    "The sum insured on this new product could go up to Rs 1 crore and will include many advanced features, besides having complete protection to policy holders and family, in any eventuality," he said.


    Apart from this, the company had also made changes to its Mediclaim 2012 product by removing some of the deficiencies, he said.


    "This is expected to be rolled out in three to four months and the improved product is also awaiting the IRDA approval," said Srinivasan, who is here for the Silver Jubilee celebrations of the company's Coimbatore Regional office.


    On the company's performance, he said it had set a target of Rs 21,000 crore as premium collection this year as against Rs 18,431 crore in 2015-16.


    As on October 30, the company had already made a premium collection of Rs 13,000 crore, an increase of 25 per cent compared to the corresponding period last year, he said.


    With a market share of 17 per cent in in the country, the company had issued 2.5 crore policies covering 35 crore people, with a claim settlement rate of 96 per cent, he said.


    On the impact of demonetisation on premium payments, Srinivasan said initially there was a drop from cash payers, "but now it is made good and business is normal."

    G Srinivasanhealth insuranceInsurance Regulatory and Development Authority of IndiaIRDA approvalIRDAI
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok